Novel Biomarkers in Pancreatic Cancer

Alessandro Coppola; Daniela Pozzi; Damiano Caputo

doi:10.3390/cancers16030628

Novel Biomarkers in Pancreatic Cancer

Cancers (Basel). 2024 Jan 31;16(3):628. doi: 10.3390/cancers16030628.

Authors

Alessandro Coppola¹, Daniela Pozzi², Damiano Caputo^{3

4}

Affiliations

¹ Department of Surgery, Sapienza University of Rome, Via Giovanni Maria Lancisi 2, 00161 Rome, Italy.
² NanoDelivery Lab, Department of Molecular Medicine, Sapienza University of Rome, Viale Regina Elena 291, 00161 Rome, Italy.
³ Fondazione Policlinico Universitario Campus Bio-Medico, Via Alvaro del Portillo 200, 00128 Rome, Italy.
⁴ Research Unit of Surgery, Department of Medicine and Surgery, University Campus Bio-Medico di Roma, Via Alvaro del Portillo 21, 00128 Rome, Italy.

Abstract

Pancreatic ductal adenocarcinoma (PDAC) represents a neoplasm with an increasing incidence in both sexes [...].

Publication types

Editorial

Grants and funding

This research received no external funding. However, some of the research leading to the works commented upon in this Editorial has received funding from the AIRC Foundation under IG 2020-ID. 24521 project—P.I. Pozzi Daniela.